| scholarly article | Q13442814 |
| P2093 | author name string | Elaine Lyon | |
| Roberta Melis | |||
| Patricia R Slev | |||
| Brian Shirts | |||
| Christiane Fauron | |||
| Gwendolyn McMillin | |||
| Lindsey M Hubley | |||
| P2860 | cites work | Genetic variation in IL28B and spontaneous clearance of hepatitis C virus | Q24596340 |
| Lambda interferon inhibits hepatitis B and C virus replication | Q27469456 | ||
| Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance | Q28255243 | ||
| Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study | Q28269827 | ||
| Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus | Q28279955 | ||
| IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy | Q29614896 | ||
| Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C | Q29619541 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin | Q33905877 | ||
| Side effects of therapy of hepatitis C and their management | Q34984142 | ||
| Global epidemiology and burden of hepatitis C. | Q35017766 | ||
| Simultaneous amplification, detection, and analysis of common mutations in the galactose-1-phosphate uridyl transferase gene | Q39253707 | ||
| Interleukin-28b: a key piece of the hepatitis C virus recovery puzzle | Q42938347 | ||
| Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection | Q42989510 | ||
| Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin. | Q42998703 | ||
| HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy | Q43001412 | ||
| Discovering rare variants by use of melting temperature shifts seen in melting curve analysis. | Q54652167 | ||
| P433 | issue | 4 | |
| P921 | main subject | genotyping | Q912147 |
| P304 | page(s) | 446-451 | |
| P577 | publication date | 2011-05-14 | |
| P1433 | published in | The Journal of Molecular Diagnostics | Q7743603 |
| P1476 | title | Simultaneous genotyping of rs12979860 and rs8099917 variants near the IL28B locus associated with HCV clearance and treatment response | |
| P478 | volume | 13 |
| Q35112286 | Demographics, clinical characteristics, IFNL3- and IFNL4- polymorphisms in a cohort of hepatitis C patients from Puerto Rico |
| Q34433087 | Interferon lambda: opportunities, risks, and uncertainties in the fight against HCV. |
| Q38584278 | Polymorphism Near the Interleukin-28B Gene and Anti-Hepatitis C Viral Response |
| Q42978115 | Randomized trial of peginterferon α-2a plus ribavirin versus peginterferon α-2b plus ribavirin for chronic hepatitis C in Japanese patients |
| Q36575497 | Recent advances in management of the HIV/HCV coinfected patient |
| Q33887760 | Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C |
| Q40326967 | Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients |
Search more.